240 related articles for article (PubMed ID: 8972552)
21. Morphine-induced catalepsy is augmented by NMDA receptor antagonists, but is partially attenuated by an AMPA receptor antagonist.
Tzschentke TM; Schmidt WJ
Eur J Pharmacol; 1996 Jan; 295(2-3):137-46. PubMed ID: 8720577
[TBL] [Abstract][Full Text] [Related]
22. Combined blockade of AMPA and NMDA glutamate receptors reduces levodopa-induced motor complications in animal models of PD.
Bibbiani F; Oh JD; Kielaite A; Collins MA; Smith C; Chase TN
Exp Neurol; 2005 Dec; 196(2):422-9. PubMed ID: 16203001
[TBL] [Abstract][Full Text] [Related]
23. Blocking the trigeminal EPSP in rat abducens motoneurons in vivo with the AMPA antagonists NBQX and GYKI 53655.
Ruiz A; Durand J
Brain Res Bull; 2000 May; 52(2):99-107. PubMed ID: 10808079
[TBL] [Abstract][Full Text] [Related]
24. Dizocilpine-like discriminative stimulus effects of competitive NMDA receptor antagonists in mice.
Geter-Douglass B; Witkin JM
Psychopharmacology (Berl); 1997 Sep; 133(1):43-50. PubMed ID: 9335079
[TBL] [Abstract][Full Text] [Related]
25. Pharmacological characterization of AMPA-induced biting behaviour in mice.
Brambilla A; Prudentino A; Grippa N; Borsini F
Eur J Pharmacol; 1996 Jun; 305(1-3):115-7. PubMed ID: 8813540
[TBL] [Abstract][Full Text] [Related]
26. Discriminative stimulus effects of NMDA, AMPA, and mGluR5 glutamate receptor ligands in methamphetamine-trained rats.
Wooters TE; Dwoskin LP; Bardo MT
Behav Pharmacol; 2011 Sep; 22(5-6):516-24. PubMed ID: 21836462
[TBL] [Abstract][Full Text] [Related]
27. Role of AMPA and NMDA receptors in the nucleus accumbens shell in turning behaviour of rats: interaction with dopamine receptors.
Ikeda H; Akiyama G; Fujii Y; Minowa R; Koshikawa N; Cools AR
Neuropharmacology; 2003 Jan; 44(1):81-7. PubMed ID: 12559124
[TBL] [Abstract][Full Text] [Related]
28. Characterization of the glutamate receptors mediating release of somatostatin from cultured hippocampal neurons.
Fontana G; De Bernardi R; Ferro F; Gemignani A; Raiteri M
J Neurochem; 1996 Jan; 66(1):161-8. PubMed ID: 8522949
[TBL] [Abstract][Full Text] [Related]
29. AMPA receptor antagonists reverse effects of extended habit training on signaled food approach responding in rats.
Bespalov AY; Harich S; Jongen-Rêlo AL; van Gaalen MM; Gross G
Psychopharmacology (Berl); 2007 Nov; 195(1):11-8. PubMed ID: 17634927
[TBL] [Abstract][Full Text] [Related]
30. Drug discrimination analysis of NMDA receptor channel blockers as nicotinic receptor antagonists in rats.
Zakharova ES; Danysz W; Bespalov AY
Psychopharmacology (Berl); 2005 Apr; 179(1):128-35. PubMed ID: 15682308
[TBL] [Abstract][Full Text] [Related]
31. Neuropeptide Y release from cultured hippocampal neurons: stimulation by glutamate acting at N-methyl-D-aspartate and AMPA receptors.
Gemignani A; Marchese S; Fontana G; Raiteri M
Neuroscience; 1997 Nov; 81(1):23-31. PubMed ID: 9300398
[TBL] [Abstract][Full Text] [Related]
32. Systemic excitatory amino acid receptor antagonists of the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor and of the N-methyl-D-aspartate (NMDA) receptor relieve mechanical hypersensitivity after transient spinal cord ischemia in rats.
Xu XJ; Hao JX; Seiger A; Wiesenfeld-Hallin Z
J Pharmacol Exp Ther; 1993 Oct; 267(1):140-4. PubMed ID: 8229741
[TBL] [Abstract][Full Text] [Related]
33. Effect of activity at metabotropic, as well as ionotropic (NMDA), glutamate receptors on morphine dependence.
Fundytus ME; Coderre TJ
Br J Pharmacol; 1994 Dec; 113(4):1215-20. PubMed ID: 7889275
[TBL] [Abstract][Full Text] [Related]
34. AMPA receptor antagonists, GYKI 52466 and NBQX, do not block the induction of long-term potentiation at therapeutically relevant concentrations.
Kapus G; Székely JI; Durand J; Ruiz A; Tarnawa I
Brain Res Bull; 2000 Aug; 52(6):511-7. PubMed ID: 10974490
[TBL] [Abstract][Full Text] [Related]
35. Pharmacological specificity of the discriminative stimulus properties of 2-amino-4,5-(1,2-cyclohexyl)-7-phosphono-heptanoic acid (NPC 12626), a competitive N-methyl-D-aspartate receptor antagonist.
Bobelis DJ; Balster RL
J Pharmacol Exp Ther; 1993 Feb; 264(2):845-53. PubMed ID: 8437128
[TBL] [Abstract][Full Text] [Related]
36. Effects of competitive and noncompetitive N-methyl-D-aspartate (NMDA) antagonists in rats trained to discriminate NMDA from saline.
Willetts J; Balster RL
J Pharmacol Exp Ther; 1989 Nov; 251(2):627-33. PubMed ID: 2553930
[TBL] [Abstract][Full Text] [Related]
37. The NMDA/glycine receptor antagonist, L-701,324, produces discriminative stimuli similar to those of ethanol.
Kotlinska J; Liljequist S
Eur J Pharmacol; 1997 Jul; 332(1):1-8. PubMed ID: 9298919
[TBL] [Abstract][Full Text] [Related]
38. Effects of AMPA receptor antagonists on dopamine-mediated behaviors in mice.
Vanover KE
Psychopharmacology (Berl); 1998 Mar; 136(2):123-31. PubMed ID: 9551768
[TBL] [Abstract][Full Text] [Related]
39. Ethanol and N-methyl-D-aspartate receptor complex interactions: a detailed drug discrimination study in the rat.
Hundt W; Danysz W; Hölter SM; Spanagel R
Psychopharmacology (Berl); 1998 Jan; 135(1):44-51. PubMed ID: 9489933
[TBL] [Abstract][Full Text] [Related]
40. Ketamine, but not MK-801, produces antidepressant-like effects in rats responding on a differential-reinforcement-of-low-rate operant schedule.
Hillhouse TM; Porter JH
Behav Pharmacol; 2014 Feb; 25(1):80-91. PubMed ID: 24370559
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
